Results of a Safety Pooled Analysis of an Adjuvanted Herpes Zoster Subunit Vaccine in More than 14,500 Participants Aged 50 Years or Older

BACKGROUND: The recombinant herpes zoster (HZ) subunit vaccine (HZ/su) has shown efficacy against HZ in adults ≥50 and ≥70 years of age (YOA), in two pivotal Phase III clinical trials (NCT01165177, NCT01165229). A pooled safety analysis of data from these two efficacy studies was performed, includin...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Open Forum Infect Dis
Autori principali: López-Fauqued, Marta, Campora, Laura, Delannois, Frédérique, El Idrissi, Mohamed, Ledent, Edouard, Diez-Domingo, Javier, McElhaney, Janet, McNeil, Shelly, De Looze, Ferdinandus, Yeo, Wilfred, Silva, Fernanda Tavares Da
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2017
Soggetti:
Abstracts
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5631020/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx163.1042
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi